307 related articles for article (PubMed ID: 25012728)
1. The limits of evidence in drug approval and availability: a case study of cilostazol and naftidrofuryl for the treatment of intermittent claudication.
Hong H; Mackey WC
Clin Ther; 2014 Aug; 36(8):1290-301. PubMed ID: 25012728
[TBL] [Abstract][Full Text] [Related]
2. A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.
Squires H; Simpson E; Meng Y; Harnan S; Stevens J; Wong R; Thomas S; Michaels J; Stansby G
Health Technol Assess; 2011 Dec; 15(40):1-210. PubMed ID: 22142554
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
Guest JF; Davie AM; Clegg JP
Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.
Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G
Br J Surg; 2012 Dec; 99(12):1630-8. PubMed ID: 23034699
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.
Meng Y; Squires H; Stevens JW; Simpson E; Harnan S; Thomas S; Michaels J; Stansby G; O'Donnell ME
Angiology; 2014 Mar; 65(3):190-7. PubMed ID: 23378195
[TBL] [Abstract][Full Text] [Related]
6. Naftidrofuryl: a review of its use in the treatment of intermittent claudication.
Goldsmith DR; Wellington K
Drugs Aging; 2005; 22(11):967-77. PubMed ID: 16323973
[TBL] [Abstract][Full Text] [Related]
7. Cilostazol: treatment of intermittent claudication.
Reilly MP; Mohler ER
Ann Pharmacother; 2001 Jan; 35(1):48-56. PubMed ID: 11197586
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
Roset PN
Br J Surg; 2013 Dec; 100(13):1838. PubMed ID: 24227374
[No Abstract] [Full Text] [Related]
9. Authors' reply: systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G
Br J Surg; 2013 Dec; 100(13):1838-9. PubMed ID: 24227373
[No Abstract] [Full Text] [Related]
10. Naftidrofuryl for intermittent claudication.
de Backer TL; Vander Stichele R; Lehert P; Van Bortel L
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD001368. PubMed ID: 23235580
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of intermittent claudication.
Doggrell SA
Expert Opin Pharmacother; 2001 Nov; 2(11):1725-36. PubMed ID: 11825312
[TBL] [Abstract][Full Text] [Related]
12. Naftidrofuryl for intermittent claudication.
De Backer TL; Vander Stichele R; Lehert P; Van Bortel L
Cochrane Database Syst Rev; 2008 Apr; (2):CD001368. PubMed ID: 18425872
[TBL] [Abstract][Full Text] [Related]
13. The US experience with cilostazol in treating intermittent claudication.
Hiatt WR
Atheroscler Suppl; 2005 Dec; 6(4):21-31. PubMed ID: 16275166
[TBL] [Abstract][Full Text] [Related]
14. The role of cilostazol in the treatment of intermittent claudication.
Barnett AH; Bradbury AW; Brittenden J; Crichton B; Donnelly R; Homer-Vanniasinkam S; Mikhailidis DP; Stansby G
Curr Med Res Opin; 2004 Oct; 20(10):1661-70. PubMed ID: 15462700
[TBL] [Abstract][Full Text] [Related]
15. New treatment options in intermittent claudication: the US experience.
Hiatt WR
Int J Clin Pract Suppl; 2001 Apr; (119):20-7. PubMed ID: 11355276
[TBL] [Abstract][Full Text] [Related]
16. Cilostazol approved for use in intermittent claudication.
Miller JL
Am J Health Syst Pharm; 1999 Mar; 56(5):404. PubMed ID: 10096695
[No Abstract] [Full Text] [Related]
17. Measuring treatment effects of cilostazol on clinical trial endpoints in patients with intermittent claudication.
Smith JA
Clin Cardiol; 2002 Mar; 25(3):91-4. PubMed ID: 11892686
[TBL] [Abstract][Full Text] [Related]
18. Evidence-based symptom relief of intermittent claudication: efficacy and safety of cilostazol.
Donnelly R
Diabetes Obes Metab; 2002 Mar; 4 Suppl 2():S20-5. PubMed ID: 12180354
[TBL] [Abstract][Full Text] [Related]
19. Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data.
De Backer T; Vander Stichele R; Lehert P; Van Bortel L
BMJ; 2009 Mar; 338():b603. PubMed ID: 19276131
[TBL] [Abstract][Full Text] [Related]
20. Drug treatment of intermittent claudication.
Jacoby D; Mohler ER
Drugs; 2004; 64(15):1657-70. PubMed ID: 15257627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
